Harrow Health, Inc. (HROW) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 44.2M | 89.09M | 71.64M | 63.74M | 47.83M | 66.83M | 49.26M | 48.94M | 34.59M | 36.35M | 34.27M | 33.47M |
| Revenue Growth % | -7.58% | 33.31% | 45.44% | 30.25% | 38.29% | 83.83% | 43.75% | 46.22% | 32.5% | 78.83% | 50.13% | 43.51% |
| Cost of Goods Sold | 17.16M | 18.47M | 17.71M | 16.23M | 15.52M | 14.13M | 12.02M | 12.54M | 10.55M | 11.3M | 10.07M | 10M |
| COGS % of Revenue | 38.82% | 20.73% | 24.72% | 25.46% | 32.46% | 21.15% | 24.4% | 25.62% | 30.51% | 31.09% | 29.38% | 29.88% |
| Gross Profit | 27.05M | 70.62M | 53.93M | 47.51M | 32.31M | 52.7M | 37.24M | 36.4M | 24.03M | 25.05M | 24.2M | 23.47M |
| Gross Margin % | 61.18% | 79.27% | 75.28% | 74.54% | 67.54% | 78.85% | 75.6% | 74.38% | 69.49% | 68.91% | 70.62% | 70.12% |
| Gross Profit Growth % | -16.29% | 34.02% | 44.81% | 30.53% | 34.42% | 110.34% | 53.89% | 55.09% | 34.78% | 76.88% | 50.28% | 39.79% |
| Operating Expenses | 49.13M | 46.58M | 39.18M | 36.1M | 43.54M | 39.8M | 35.92M | 34.87M | 30.96M | 29.93M | 22.45M | 21.12M |
| OpEx % of Revenue | 111.14% | 52.29% | 54.69% | 56.64% | 91.03% | 59.55% | 72.92% | 71.25% | 89.52% | 82.32% | 65.53% | 63.1% |
| Selling, General & Admin | 43.23M | 43.31M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A % of Revenue | 97.8% | 48.61% | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 5.89M | 3.27M | 3.32M | 2.87M | 3.03M | 4.75M | 2.27M | 3.05M | 2.15M | 3.34M | 1.42M | 1.16M |
| R&D % of Revenue | 13.34% | 3.67% | 4.64% | 4.5% | 6.33% | 7.12% | 4.61% | 6.24% | 6.21% | 9.18% | 4.15% | 3.47% |
| Other Operating Expenses | 0 | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Operating Income | -22.08M | 24.04M | 14.75M | 11.41M | -11.23M | 12.9M | 1.32M | 1.53M | -6.93M | -4.88M | 1.74M | 2.35M |
| Operating Margin % | -49.95% | 26.98% | 20.59% | 17.9% | -23.48% | 19.3% | 2.68% | 3.13% | -20.03% | -13.41% | 5.09% | 7.03% |
| Operating Income Growth % | -96.58% | 86.38% | 1016.35% | 645.69% | -62.12% | 364.59% | -24.25% | -34.95% | -672.56% | -174.18% | 1955.32% | 39.17% |
| EBITDA | -16.5M | 28.82M | 19.31M | 15.98M | -6.69M | 17.3M | 4.28M | 4.38M | -4.08M | -2.12M | 4.62M | 5.42M |
| EBITDA Margin % | -37.32% | 32.35% | 26.96% | 25.07% | -14% | 25.88% | 8.68% | 8.95% | -11.79% | -5.82% | 13.48% | 16.2% |
| EBITDA Growth % | -146.43% | 66.64% | 351.55% | 264.89% | -64.15% | 917.73% | -7.38% | -19.23% | -211.97% | -96.74% | 872.21% | 119.64% |
| D&A (Non-Cash Add-back) | 5.58M | 4.78M | 4.57M | 4.57M | 4.54M | 4.4M | 2.96M | 2.85M | 2.85M | 2.76M | 2.87M | 3.07M |
| EBIT | -22.08M | 24.04M | 7.06M | 11.41M | -11.23M | 13.15M | 1.32M | 1.53M | -6.93M | -4.5M | 1.74M | 2.35M |
| Net Interest Income | -5.5M | -5.19M | -6.04M | -6.41M | -6.55M | -6.38M | -5.53M | -5.47M | -5.42M | -5.12M | -5.75M | -5.7M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 5.5M | 5.19M | 6.04M | 6.41M | 6.55M | 6.38M | 5.53M | 5.47M | 5.42M | 5.12M | 5.75M | 5.7M |
| Other Income/Expense | -5.5M | -13.64M | -13.73M | -6.41M | -6.55M | -6.64M | -5.52M | -7.35M | -6.64M | -4.81M | -4.6M | -6.6M |
| Pretax Income | -27.58M | 10.4M | 1.02M | 5M | -17.78M | 6.26M | -4.2M | -5.82M | -13.56M | -9.68M | -2.85M | -4.24M |
| Pretax Margin % | -62.39% | 11.67% | 1.42% | 7.84% | -37.17% | 9.37% | -8.53% | -11.89% | -39.22% | -26.63% | -8.32% | -12.68% |
| Income Tax | 25K | 3.77M | 0 | 0 | 0 | -514K | 20K | 655K | 0 | -535K | 1.54M | -15K |
| Effective Tax Rate % | -0.09% | 36.27% | 0% | 0% | 0% | -8.21% | -0.48% | -11.26% | 0% | 5.53% | -53.96% | 0.35% |
| Net Income | -27.6M | 6.63M | 1.02M | 5M | -17.78M | 6.78M | -4.22M | -6.47M | -13.56M | -9.15M | -4.39M | -4.23M |
| Net Margin % | -62.44% | 7.44% | 1.42% | 7.84% | -37.17% | 10.14% | -8.57% | -13.23% | -39.22% | -25.16% | -12.81% | -12.64% |
| Net Income Growth % | -55.24% | -2.23% | 124.17% | 177.17% | -31.07% | 174.08% | 3.89% | -53.06% | -104.2% | -967.11% | 32.07% | 32.22% |
| Net Income (Continuing) | -27.6M | 6.63M | 1.02M | 5M | -17.78M | 6.78M | -4.22M | -6.47M | -13.56M | -9.15M | -4.39M | -4.23M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | -355K | -355K | -355K | -355K | -355K | -355K | -355K | -355K | -355K | -355K | -355K | -355K |
| EPS (Diluted) | -0.74 | 0.18 | 0.03 | 0.13 | -0.50 | 0.19 | -0.12 | -0.18 | -0.38 | -0.26 | -0.13 | -0.14 |
| EPS Growth % | -48% | -5.26% | 121.83% | 172.22% | -31.58% | 173.08% | 7.69% | -28.57% | -72.73% | -826.26% | 45.83% | 39.13% |
| EPS (Basic) | -0.74 | 0.18 | 0.03 | 0.14 | -0.50 | 0.19 | -0.12 | -0.18 | -0.38 | -0.26 | -0.13 | -0.14 |
| Diluted Shares Outstanding | 37.23M | 36.76M | 38.88M | 38.85M | 35.83M | 35.81M | 35.7M | 35.62M | 35.47M | 35.35M | 34.26M | 30.46M |
| Basic Shares Outstanding | 37.23M | 36.76M | 37.15M | 36.79M | 35.83M | 35.81M | 35.7M | 35.62M | 35.47M | 35.35M | 34.26M | 30.46M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |